Interests and limits of immunocontraception;Intérêts et limites de l'immunocontraception

Gynecologie Obstetrique et Fertilite

Volumn 31, Issue 9, 2003, Pages 774-777

  Abdennebi Najar, L ^a  

^a ISAB   (France)

Author keywords

Fertility; Immunocontraception; Reproduction; Vaccine

Indexed keywords

ANTIGEN; CHORIONIC GONADOTROPIN; CONTRACEPTIVE VACCINE; FOLLITROPIN; FOLLITROPIN RECEPTOR; GONADORELIN; GONADOTROPIN; LUTEINIZING HORMONE; TESTOSTERONE;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN DETECTION; ANTIGEN FUNCTION; BIRTH CONTROL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; FEMALE; GONADOTROPIN RELEASE; HORMONE INHIBITION; IMMUNIZATION; IMMUNOCONTRACEPTION; MALE; MALE FERTILITY; NONHUMAN; OOCYTE; PHAGE DISPLAY; REPRODUCTION; SEXUAL BEHAVIOR; SPERM; SPERMATOGENESIS; SPERMATOZOON; TECHNIQUE; TESTOSTERONE BLOOD LEVEL; VACCINATION;

EID: 0141682691     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/S1297-9589(03)00218-2     Document Type: Conference Paper

References (25)

1. Aitken RJ. Immunocontraceptive vaccines for human use. J Reprod Immunol 2002;57:273-87.
2. Van Voorhis BJ, Stovall DW. Autoantibodies and infertility: a review of the literature. J Reprod Immunol 1997;33:239-45.
3. O'Hearn P, Barbara C, Isahakia M, Godberg E. Reversible contraception in female baboons immunized with a synthetic epitope of sperm specific LDH. Biol Reprod 1995;52:331-9.
4. Frayne J, Hall L. The potential use of sperm antigens as targets for immunocontraception; past, present and future. J Reprod Immunol 1999;43:1-33.
5. Ramsay AJ, Ramshaw IA. Cytokine enhancement of immune. responses important for immunocontraception. Reprod Fertil Dev 1997;9:91-7.
6. Norton EJ, Diekman AB, Westbrook VA, Flickinger CJ, Herr JC. RASA, a recombinant single chain variable fragment (ScFv) antibody directed against the human sperm surface. Implications for novel contraceptives. Hum Reprod 2001;16:1854-60.
7. Delves PJ, Lund T, Roitt IM. Antifertility vaccines. Trends in Immunology 2002;23(4):213-9.
8. Rankin T, Familari M, Le E, Ginsberg A, Dwyer N, Blanchette-Mackie J, et al. Mice homozygous for an insertional mutation in the ZP3 gene lack a zona pellucida and are infertile. Development 1996; 122:2903-10.
9. VandeVoort CA, Schwoebel ED, Dunbar BS. Immunization of monkeys with recombinant complementary deoxyribonucleic acid expressed zona pellucida proteins. Fertil Steril 1995;64:838-47.
10. Martinez ML, Harris JD. Effectiveness of zona pellucida protein ZPB as an immunocontraceptive antigen. J Reprod Fertil 2000;120:19-32.
11. Aitken RJ, Paterson M, Van Duin M. The potential of zona pellucida as a target for immunocontraception. Am J Reprod Immunol 1996;35:175-80.
12. Paterson M, Koothan PT, Morris KD, O'Byrne KT, Braude P, Williams A, et al. Analysis of contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and in vitro. Biol Reprod 1992;46:523-34.
13. Govind CK, Hasegawa A, Koyama K, Gupta SK. Delineation of a conserved B-cell epitope on Bonnet Monkey (Macaca radiata) and human zona pellucida glycoprotein B by monoclonal antibodies demonstrating inhibition of sperm-egg binding. Biol Reprod 2000;62:67-75.
14. Paterson M, Jennings ZA, Wilson MR, Aitken RJ. The contraceptive potential of ZP3 and ZP3 peptides in primate. J Reprod Immunol 2002;53:99-107.
15. Ladd A, Tsong YY, Lok J. Active immunization against LHRH: I: Effects of conjugation site and dose. Am J Reprod immunol 1990:22-56.
16. Ferro VA, Stimson WH. Immunoneutralisation of gonadotrophin-releasing hormone: a potential treatment for oestrogen-dependent breast cancer. Eur J Cancer 1997;33:1468-78.
17. Talwar GP, Singh O, Pal R, Chatteerjee N, Sahai P, Dhall K, et al. A vaccine that prevents pregnancy in women. Proc Natl Acad Sci USA 1994;91:8532-6.
18. Talwar GP. Fertility regulating and immunotherapeutic vaccines reaching human trials stage. Hum Reprod Update 1997;3:301-10.
19. Stevens VC. Antifertility vaccines. In: Perlmann P, Wigzell H, editors. Handbook of Experimental Pharmacology. Springer-Verlag; 1999. p. 443-61.
20. Talwar GP. 1999. Vaccines and passive immununological approaches for the control of fertility and hormone dependent cancers. Immunol Rev 1999;171:173-92.
21. Porakishvili N, Jackson AM, de Souza JB, Dalla Chiesa M, Roitt IM, Delves PJ, et al. Epitopes of human chorionic gonadotropin and their relationship to immunogenicity and cross reactivity of beta chain mutants. Am J Reprod Immunol 1998;40:210-4.
22. McLachlan RI, O'Donnell L, Meachem SJ, Stanton PG, De K, Pratis K, et al. Hormonal regulation of spermatogenesis in primates and man: insights for development of the male hormonal contraceptive. J Androl 2002;23:149-62.
23. Moudgal NR, Sairam MR. Is there a true requirement for follicle stimulating hormone in promoting spermatogenesis and fertility in primates. Hum Reprod 1998;13(4):916-29.
24. Moudgal NR, Dighe RR. Is FSH-based contraceptive vaccine a feasible proposition for the human male? In: Gupta SK, editor. Reproductive Immunology. Narosa Press; 1999. p. 346-57.
25. Abdennebi L, Couture L, Grebert D, Pajot E, Salesse R, Remy J-J. Generating FSH antagonists and agonists through immunization against FSH receptor N-terminal decapeptides. J Mol Endoc 1999;22(2):151-9.